Ensera Launches Alliance Network with Industry Leaders

DUBLIN, Oct. 1, 2026 – Ensera, a global CDMO, has announced the creation of the Ensera Alliance Network, aimed at streamlining the commercialization of drug-device combination products. This initiative brings together key players in the industry, including SHL Medical, Stevanato Group, Ypsomed, Argonaut Manufacturing Services, and American Injectables.

The collaboration seeks to simplify the often complex process of bringing combination products to market by integrating efforts across device platforms, fill-finish processes, and final assembly and packaging. This approach is designed to minimize delays and ensure alignment of responsibilities and timelines.

Bobby O'Connor, Chief Commercial Officer at Ensera, emphasized that the network will facilitate quicker market launches by reducing the risks linked to disconnected supplier processes. Ensera plans to expand this non-exclusive network, fostering partnerships that align with the needs of its clients.